Document is current
Any future updates will be listed below
-
Authors
Kariniemi, Kaisa
Vääräsmäki, Marja
Männistö, Tuija
Mustaniemi, Sanna
Kajantie, Eero
Eteläinen, Sanna
Keikkala, Elina
,
Pouta, Anneli
Kaaja, Risto
Eriksson, Johan G
Laivuori, Hannele
Gissler, Mika
-
Funding
Funding for this research was provided by:
Academy of Finland
Signe ja Ane Gyllenbergin Säätiö
Diabetestutkimussäätiö
Novo Nordisk Foundation
Juho Vainion Säätiö
Sigrid Juséliuksen Säätiö
Lastentautien Tutkimussäätiö
Sydäntutkimussäätiö
University of Oulu Graduate School
Terttu Foundation
Oulun Yliopistollinen Sairaala
Suomen Lääketieteen Säätiö
University of Oulu
- License Information
-
More Information
Article History
Received: 22 December 2023
Accepted: 31 March 2024
First Online: 12 April 2024
Declarations
:
: According to the Finnish Act on Secondary Use of Health and Social Data 552/2019, the study participants did not need to provide an information consent form when only anonymous register data were used. The Finnish Institute for Health and Welfare gave their permission for the use of the MBR data (Number: THL132/5.05.00/2011). Hospital administration gave permission to use and combine OGTT laboratory test results with the register data. The FinnGeDi study was approved by the regional ethics committee in Northern Ostrobothnia Hospital District (Number: 2008/43, date of approval: 2008–6-19).
: Not applicable.
: The authors declare no competing interests.
